This document provides guidance on conducting audits to assess appropriate use of venous thromboembolism (VTE) prophylaxis in hospitals. It describes snap-shot and detailed audits, resources needed, steps to conduct audits, and how to report and disseminate results to drive quality improvement. The goal is to help close any gaps between evidence-based guidelines and actual clinical practice of VTE prophylaxis prescription and use.
This presentation has the measures to be taken for the safety of patients. It covers the 6 goals
Goal 1: Identify patients correctly
Goal 2: Improve effective communication
Goal 3: Improve the safety of high-alert medications
Goal 4: Ensure safe surgery
Goal 5: Reduce the risk of health care-associated infections
Goal 6: Reduce the risk of patient harm resulting from falls
This presentation has the measures to be taken for the safety of patients. It covers the 6 goals
Goal 1: Identify patients correctly
Goal 2: Improve effective communication
Goal 3: Improve the safety of high-alert medications
Goal 4: Ensure safe surgery
Goal 5: Reduce the risk of health care-associated infections
Goal 6: Reduce the risk of patient harm resulting from falls
Clinical Audit is a method of confirming the quality of clinical services and identify the need for improvement. A skill hospital administrator should learn and practice.
ICTS is a clinical trials support company that specializes in achieving superior results in research studies by building and maintaining stronger connections throughout the entire clinical trial process. Our innovative and customized communication models provide the foundation for higher quality data and results.
How Clinical Decision Support Systems (CDSS) is the right tool for physicians?Eurostars Programme EUREKA
We believe that CDSS delivered using information systems, ideally with the electronic medical record as the platform, will finally provide decision makers with tools making it possible to achieve large gains in performance, narrow gaps between knowledge and practice, and improve safety.
Prof Devlin discusses the rationale for the PROMs programme and provides an overview of the various uses of the EQ-5D in England—for example by NICE in health technology assessment, in population surveys and in the English NHS PROMS program. The presentation also reviews how EQ-5D data are collected, analysed and used in the UK to inform decisions by health care providers, payers and patients.
Clinical Audit is a method of confirming the quality of clinical services and identify the need for improvement. A skill hospital administrator should learn and practice.
ICTS is a clinical trials support company that specializes in achieving superior results in research studies by building and maintaining stronger connections throughout the entire clinical trial process. Our innovative and customized communication models provide the foundation for higher quality data and results.
How Clinical Decision Support Systems (CDSS) is the right tool for physicians?Eurostars Programme EUREKA
We believe that CDSS delivered using information systems, ideally with the electronic medical record as the platform, will finally provide decision makers with tools making it possible to achieve large gains in performance, narrow gaps between knowledge and practice, and improve safety.
Prof Devlin discusses the rationale for the PROMs programme and provides an overview of the various uses of the EQ-5D in England—for example by NICE in health technology assessment, in population surveys and in the English NHS PROMS program. The presentation also reviews how EQ-5D data are collected, analysed and used in the UK to inform decisions by health care providers, payers and patients.
Patient Blood Management: Impact of Quality Data on Patient OutcomesViewics
Patient blood management (PBM) has been proven to improve patient outcomes and save hospitals millions of dollars. Ensuring the quality of your data is central to decision making and critical to having a strong PBM program.
Would you like to learn how your organization can improve patient outcomes by implementing a PBM program based on accurate data?
If so, view this presentation by blood management expert Lance Trewhella. Lance presents how to develop a successful, evidence-based, multidisciplinary PBM program aimed at optimizing the care of patients who might need transfusion.
You’ll learn:
• Current recommendations for blood transfusion utilization
• The impact of quality data on PBM programs
• Best data practices in PBM
Health IT Summit Houston 2014 - Case Study "EHR Optimization for Organizational Value in a Changing Healthcare Environment"
Luis Saldana, MD, MBA, FACEP
CMIO
Texas Health Resources
iHT2 case studies and presentations illustrate challenges, successes and various factors in the outcomes of numerous types of health IT implementations. They are interactive and dynamic sessions providing opportunity for dialogue, debate and exchanging ideas and best practices. This session will be presented by a thought leader in the provider, payer or government space.
> Why HEOR?
> Costs, Consequences and Perspectives
> Key Stakeholders in HEOR
> What is Health Economics and Pharmaco-economic Research?
> Economic Evaluations
> Incremental Cost Effectiveness Ratio (ICER)
> Concept of HRQoL
> Comparative Effectiveness Research (CER)
> Pragmatic Clinical Trials
> Observational Studies
> Systematic Reviews and Meta-Analysis
> Application of CER
> Health Technology Assessment (HTA)
> Real World Evidence (RWE)
> Patient Reported Outcomes (PROs)
> Patient Focused Drug Development (PFDD)
> Application of Health Economic Evaluations
> Challenges and Barriers
Clinical practice guidelines are “systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances.”They are intended to offer concise instructions on how to provide healthcare services.The most important benefit of clinical practice guidelines is their potential to improve both the quality or process of care and patient outcomes. Increasingly, clinicians and clinical managers must choose from numerous, sometimes differing, and occasionally contradictory, guidelines.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
2. ACCREDITATION CANADA
2010 VTE Prophylaxis ROP
1. The hospital has an organization-wide, written
thromboprophylaxis policy or guideline.
2. Identifies patients at risk for VTE and provides
appropriate, evidence-based VTE prophylaxis.
3. Establishes measures for appropriate
thromboprophylaxis use, audit its
implementation, and uses this for quality
improvement.
4. Identifies major orthopedic surgery patients who
require post-discharge prophylaxis and provides
it.
5. Educates health professionals and patients about
VTE and its prevention.
www.accreditation.ca
3. Why do Audits?
Audits and feedback are an effective
strategy to identify gaps between
evidence and practice, and should
drive change in healthcare settings.
4. • It will help identify gaps between the evidence
(embedded into the local thromboprophylaxis
policy) and what is actually done in practice.
• Will be used to guide where to implement quality
improvement (QI) interventions.
• Should assess the proportion of patients at risk
for VTE who are prescribed appropriate
(evidence-based) VTE prophylaxis
− capturing correct option, dose, onset, compliance and,
where possible, duration.
What will a VTE prophylaxis
audit tell us?
5. • Data collection/generation
• Computerized pharmacy system (ability to generate
Drug Use Evaluation (DUE) reports)
• Data Collection Tables
• Supplemental Data Collection sheets
• Staffing resources
• Pharmacy staff: pharmacists, pharmacy students
• Quality Improvement: QI personnel
• Nurses
• Research Personnel
• Medical Students
• Health Records Analysts
• Other Health Personnel
Resources and Considerations
for an Audit
6. Choosing an Audit Type
Snap-Shot Audit Detailed Audit
Purpose:
To identify prevalence of
thromboprophylaxis use in one or
more patient groups.
Purpose:
To identify prevalence and
appropriateness of
thromboprophylaxis
Key Points:
•Provides point estimates of the
use of local TP options
•Indicates if evidence-based TP is
prescribed/ordered on that given
day
•Easy and most efficient audit
•Provides estimate of how well the
various services are doing
•Helps identify possible care gaps
•Provides a measure that could be
utilized for dashboards/balanced
scorecards if used as a measure of
quality of care
Key Points:
•Captures appropriate selection of
TP option, initiation, and dose
•Requires direct auditing of a
greater number of charts (DUE
reports are not sufficient), making
it more labour intensive
•Provides more useful information
and more appropriate estimates
7. Audit Advantages & Limitations
Snap-Shot Audit Detailed Audit
Advantages:
•Estimate of TP
•Quick
•Identifies major gaps in the
provision of local TP options
•Less labour intensive
•Can be completed by personnel
with less clinical experience
Advantages:
•Can provide information on
initiation, dose, adherence (if and
when given), and duration of TP
•Estimates and provides greater
insight into suboptimal TP use,
leading to the creation of remedial
Quality Improvement (QI)
strategies
Limitations:
•Does not measure appropriateness,
initiation, dose, adherence, or
duration of TP
Limitation
•Requires the direct review of
actual patient charts (DUE not
enough
•Labour intensive
•Requires personnel with clinical
experience
8. • Where a pharmacy informatics system is in place
generate a report indicating patients currently
receiving any anticoagulant
Audit Steps
10. IMPORTANT:
Audit tools should be aligned
with
policy/ guidelines
of your institution
or
consistent with clinical order
set
11. • For real-time detailed audits, options are:
• all beds on a given day
or
• audit different services/wards/nursing care
units on consecutive days
or
• audit a single or limited number of nursing care
units
Frequency and Audit Sample
As rates of appropriate prophylaxis
increase less time will be needed,
with fewer chart audits required.
12. • Only patients who are determined NOT to be on
an anticoagulant will require a chart review
• All patients captured by the DUE as being on an
anticoagulant can be classified as receiving
therapeutic or prophylactic anticoagulation
• Patients not appearing on the DUE report require a
chart audit to determine if they are receiving
mechanical prophylaxis or no prophylaxis and
whether those decisions are appropriate
Snap-Shot Audit
18. • To drive change the results must be
shared/disseminated with stakeholders, including
healthcare providers and administration.
• Data should be broken down at various levels
including:
• Hospital Service
• Ward Individual Physician
• Wards/ service areas should be provided with
outcomes from the audit to assist them with
improving patient safety and care.
Driving Change Toward Best
Practices
20. Various methods of dissemination include:
− Newsletters
− Educational/in-service sessions
− Department Head meetings
− P&T
− Organizational public newsletters
Dissemination of Audit Results
21. The Goal of every
Hospital/Institute:
100% appropriate
prophylaxis for all patients
at risk,
when clinically indicated
Editor's Notes
Speaker Notes: 60-70% of all VTE is hospital-acquired (i.e. this is a public health issue). Pulmonary embolism is the commonest, preventable cause of hospital death. These facts support the Accreditation Canada VTE ROP which recommends that the team establish measures for appropriate thromboprophylaxis use, audits the implementation of appropriate thromboprophylaxis, and uses this information to make improvements to their services. “ Patients without risk factors for VTE are called outpatients .” G. Maynard (2010)
Speaker Notes: Numerous audit methodologies are available that consider the following: the depth of information desired (snap-shot vs. detailed) timing with respect to a patient’s admission (real-time vs. retrospective)
Speaker Notes: Importantly, the audit methodology (snap-shot vs. detailed) should be consistent with your local VTE prophylaxis policy/guideline.
Speaker Notes: The type of audit your institution chooses to perform will depend upon the resources available to conduct the audit, as well as the type and depth of information sought. Once the audit type has been decided then resources need to be determined and allocated.
Speakers Notes: A VTE prophylaxis audit should assess the proportion of patients receiving recommended or indicated prophylaxis and/or appropriately prescribed prophylaxis (capturing onset, type and duration) Appropriate thromboprophylaxis should be: 1 provided within 24 hours of admission to hospital and within 24 hours following major l surgical procedures involve evidence-based (ACCP recommended) thromboprophylaxis continued until hospital discharge or post-discharge for selected patient groups, if appropriate (at least until hospital discharge in major non-orthopedic surgical patients and at least 10 days for hip/knee arthroplasty or hip fracture surgery) Reference: Geerts WH, et al . Prevention of venous thromboembolism: ACCP evidence-based clinical practice guidelines, 8 th edition. Chest 2008;133:381S-453S.
Speaker Notes: At some point in time each audit methodology, both snapshot and in-depth, should be performed to ensure a complete audit/review of thromboprophylaxis practices is conducted, with the information gained being used for quality improvement purposes.
Speaker Notes: In situations where a pharmacy informatics system is in place, the appropriate pharmacy personnel will/should generate a report indicating patients currently receiving any anticoagulant, including LMWH, LDUH, warfarin, rivaroxaban and dabigatran. All patients that are captured by the DUE report as being on an anticoagulant can be classified as receiving therapeutic or prophylactic anticoagulation. Patients not appearing on the DUE report require a chart audit to determine if they are receiving mechanical thromboprophylaxis or no thromboprophylaxis and whether those decisions are appropriate.
Speaker Notes: Important for any audit is that every patient be accounted for including those who do not require thromboprophylaxis due to a lack of indication. If the entire hospital will be audited consider excluding some patient groups where there are no clear guidelines regarding appropriate thromboprophylaxis: paediatric psychiatric palliative/long-term care rehab
Speakers Notes: On average, an organization wide point-in-time audit in a 400-bed hospital with moderate rates of thromboprophylaxis will require 4-8 hours, depending on audit staff efficiency. With experience, significant improvements in efficiency will be noted.
Speaker Notes: For a snap-shot audit, only patients who are determined NOT to be on an anticoagulant will require a chart review. All patients that are captured by the DUE report as being on an anticoagulant can be classified as receiving therapeutic or prophylactic anticoagulation. Patients not appearing on the DUE report require a chart audit to determine if they are receiving mechanical thromboprophylaxis or no thromboprophylaxis and whether those decisions are appropriate. For each patient who requires a chart review, this review can be used to determine if they have contraindications to a pharmacological agent, received mechanical thromboprophylaxis, or did not have an indication for thromboprophylaxis.
Speaker Notes: The data collection forms should be adapted to fit the policy/guideline of your hospital. These examples are very comprehensive and offer a good start point for designing you own data collection forms. It is important that a SUMMARY section be provided to capture the key point of a patient’s risk and treatment (if any).
Speaker Notes: The data collection table should be adapted to fit the policy/guideline of your hospital. This example is a good start point for designing you own tables.
Speaker Notes: Once the audit is complete a report should be generated. Most helpful is comparisons to previous audits to clearly show successes and care gaps.
Speaker Notes: In this case the success should be celebrated (83%, 10% better than 2010) and the gaps identified (missing 17%). It is important that a strategy be worked out to support continued improvement. Vigilance in awareness and improvements are key to a backwards slide.
Speaker Notes: In order for audit results to drive change toward best practices, it is important that the results be shared/disseminated to stakeholders, including healthcare providers and hospital/institution administration.
Speaker Notes: Next steps to drive awareness and change should be built into the audit report. Care units/wards/service areas should be provided with outcomes from the audit to assist them with improving their patient management.
Speaker Notes: Wide dissemination is key to success. Displaying the results in prominent locations such as the hospital entrances, nursing care unit/ward entrances, staff washrooms, staff locker room or lunch rooms will raise awareness and ensure the majority of staff are made aware of the outcome, successes and gaps.
Speaker Notes: This is the goal. Protection and prevention of VTE in all our patients.